Literature DB >> 19183553

Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress.

Eui Man Jeong1, Chai-Wan Kim, Sung-Yup Cho, Gi-Yong Jang, Dong-Myung Shin, Ju-Hong Jeon, In-Gyu Kim.   

Abstract

Transglutaminase 2 (TG2) is a calcium-dependent enzyme that catalyzes the transamidation reaction. There is conflicting evidence on the role of TG2 in apoptosis. In this report, we show that TG2 increases in response to low level of oxidative stress, whereas TG2 diminishes under high stress conditions. Monitoring TG2 expression, activity and calcium concentration in cells treated with A23187 revealed that the initial rise of calcium activates TG2 but subsequent calcium-overload induces the degradation of TG2 via calcium-mediated polyubiquitination. These results indicate that the role of TG2 in apoptosis depends on the level of calcium influx triggered by oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183553     DOI: 10.1016/j.febslet.2009.01.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.

Authors:  Sung-Yup Cho; Eui Man Jeong; Jin-Haeng Lee; Hyo-Jun Kim; Jisun Lim; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; Kyungho Choi; In-Gyu Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

3.  Respiratory syncytial virus infection induces the release of transglutaminase 2 from human airway epithelial cells.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Yashoda M Hosakote
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-27       Impact factor: 5.464

4.  The redox state of transglutaminase 2 controls arterial remodeling.

Authors:  Jeroen van den Akker; Ed VanBavel; Remon van Geel; Hanke L Matlung; Bilge Guvenc Tuna; George M C Janssen; Peter A van Veelen; Wilbert C Boelens; Jo G R De Mey; Erik N T P Bakker
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

5.  Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation.

Authors:  Jeroen van den Akker; Angela van Weert; Gijs Afink; Erik N T P Bakker; Edwin van der Pol; Anita N Böing; Rienk Nieuwland; Ed VanBavel
Journal:  Amino Acids       Date:  2011-08-10       Impact factor: 3.520

6.  Intimal hyperplasia in loop-injured carotid arteries is attenuated in transglutaminase 2-null mice.

Authors:  Seung-Kee Min; Sang-Il Min; Eui Man Jeong; Sung-Yup Cho; Jongwon Ha; Sang Joon Kim; In-Gyu Kim
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

Review 7.  Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.

Authors:  Gi Eob Kim; Hyun Ho Park
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

8.  Transglutaminase 2 mediates hypoxia-induced selective mRNA translation via polyamination of 4EBPs.

Authors:  Sung-Yup Cho; Seungun Lee; Jeonghun Yeom; Hyo-Jun Kim; Jin-Haeng Lee; Ji-Woong Shin; Mee-Ae Kwon; Ki Baek Lee; Eui Man Jeong; Hee Sung Ahn; Dong-Myung Shin; Kyunggon Kim; In-Gyu Kim
Journal:  Life Sci Alliance       Date:  2020-02-19

9.  Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.

Authors:  Ambrish Kumar; Jianjun Hu; Holly A LaVoie; Kenneth B Walsh; Donald J DiPette; Ugra S Singh
Journal:  BMC Cancer       Date:  2014-04-11       Impact factor: 4.430

10.  Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states.

Authors:  Mauro Piacentini; Manuela D'Eletto; Maria Grazia Farrace; Carlo Rodolfo; Franca Del Nonno; Giuseppe Ippolito; Laura Falasca
Journal:  Cell Tissue Res       Date:  2014-09-11       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.